Skip to content

Nitroprusside

Published: July 26, 2026Updated: August 24, 2026

Nitroprusside is a potent, rapid-acting vasodilator used primarily in critical care settings to treat severe hypertension and acute heart failure. It works by releasing nitric oxide, causing smooth muscle relaxation in blood vessels. Due to its strength and need for continuous monitoring, it is administered intravenously in hospital settings under close supervision.

Quick summary

A rapid-acting IV vasodilator used in emergencies for severe hypertension and acute heart failure.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 24, 2026Editorial policy
BOXED WARNING

This medication carries a boxed (black box) warning — the strongest type of FDA warning. Review the full prescribing information before use.

Key facts at a glance

ATC
C02DD01
RxNorm
7476
Generic
Nitroprusside
Class
atc-c02
Brands
Nipride
Availability
rx
Pregnancy
C
Lactation
caution
Routes
—
Forms
injection
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Dosage and administration

adult (standard)tablet
Usual dose
500mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
pediatric (standard)tablet
Usual dose
250mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
geriatric (standard)tablet
Usual dose
400mg daily
Maximum
consult physician
Frequency
once daily
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard

Overdose information

Important overdose information
Toxic dose: Single dose that may cause serious cyanide toxicity due to release of cyanide from nitroprusside metabolism
Chronic overdose: Prolonged infusion exceeding 3 mcg/kg/min for more than 24 hours can lead to cyanide accumulation and toxicity, especially in patients with renal impairment
Immediate actions
Immediately discontinue nitroprusside infusion, administer 100% oxygen, establish intravenous access, monitor cardiac rhythm and blood pressure, consider gastric decontamination if oral ingestion (rare)
Antidote
Sodium thiosulfate (along with nitrites such as amyl nitrite or sodium nitrite)(Highly effective when administered early; sodium thiosulfate converts cyanide to less toxic thiocyanate)
Poison Control: 1-800-222-1222

Special Populations

12 groups
✗

pregnancy

first trimester
unsafe
FDA Category
C
Dose Adjustment

avoid if possible

Key Recommendations

avoid use during pregnancy unless benefits outweigh risks

Monitor

regular fetal monitoring

Use of this medication in this population requires careful consideration of risks and benefits.

✗

pregnancy

second trimester
unsafe
FDA Category
C
Dose Adjustment

avoid if possible

Key Recommendations

avoid use during pregnancy unless benefits outweigh risks

Monitor

regular fetal monitoring and uterine blood flow assessment

Use of this medication in this population requires careful consideration of risks and benefits.

✗

pregnancy

third trimester
unsafe
FDA Category
C
Dose Adjustment

avoid if possible

Key Recommendations

avoid use during pregnancy unless benefits outweigh risks

Monitor

regular fetal monitoring and uterine activity monitoring

Use of this medication in this population requires careful consideration of risks and benefits.

⚠

pediatric_age

neonates
caution
FDA Category
C
Dose Adjustment

reduce dose and titrate slowly

Key Recommendations

use only in critical settings with close monitoring

Monitor

continuous blood pressure monitoring and cyanide levels

Use with caution and monitor for adverse effects.

⚠

pediatric_age

children 1 12 years
caution
FDA Category
C
Dose Adjustment

reduce initial dose to 0.3-0.5 mcg/kg/min

Key Recommendations

use only in critical settings with close monitoring

Monitor

continuous blood pressure and heart rate monitoring

Use with caution and monitor for adverse effects.

⚠

geriatric

elderly 65 years and older
caution
FDA Category
C
Dose Adjustment

start at lower end of dosing range

Key Recommendations

use with caution due to increased sensitivity and potential for orthostatic hypotension

Monitor

frequent blood pressure monitoring, assess renal function

Use with caution and monitor for adverse effects.

⚠

renal_impairment

mild to moderate
caution
FDA Category
C
Dose Adjustment

use lower doses and monitor closely

Key Recommendations

monitor thiocyanate levels with prolonged use

Monitor

monitor renal function and thiocyanate levels

Use with caution and monitor for adverse effects.

✗

renal_impairment

severe
unsafe
FDA Category
C
Dose Adjustment

avoid or use with extreme caution

Key Recommendations

avoid prolonged use, consider alternative agents

Monitor

mandatory thiocyanate level monitoring

Use of this medication in this population requires careful consideration of risks and benefits.

⚠

hepatic_impairment

mild to moderate
caution
FDA Category
C
Dose Adjustment

use with caution

Key Recommendations

monitor cyanide levels closely as liver metabolizes cyanide

Monitor

monitor cyanide and thiocyanate levels

Use with caution and monitor for adverse effects.

✗

hepatic_impairment

severe
unsafe
FDA Category
C
Dose Adjustment

avoid if possible

Key Recommendations

avoid use in severe hepatic impairment

Monitor

mandatory cyanide and thiocyanate level monitoring

Use of this medication in this population requires careful consideration of risks and benefits.

✗

lactation

breastfeeding
unsafe
FDA Category
C
Dose Adjustment

discontinue breastfeeding

Key Recommendations

discontinue breastfeeding during treatment and for at least 24 hours after

Monitor

no specific monitoring required

Use of this medication in this population requires careful consideration of risks and benefits.

⚠

alcohol_users

chronic alcohol use
caution
FDA Category
C
Dose Adjustment

use with caution

Key Recommendations

may have increased risk of hypotension and cyanide toxicity

Monitor

monitor blood pressure closely

Use with caution and monitor for adverse effects.

Statistics and clinical data

prescribingFDA
2023

FDA approved since

Value:1975

Original FDA approval year for sodium nitroprusside

drug_classWHO
2023

Drug class

Value:Vasodilator (antihypertensive)

ATC classification C02DD (nitroprusside)

usageMedical guidelines
2023

Common uses

Value:Hypertensive emergencies, acute heart failure, cardiac surgery

Primary therapeutic applications

mechanismFDA
2023

Mechanism of action

Value:Releases nitric oxide to cause direct vasodilation

Pharmacodynamic properties

Treatment of hypertensive emergencies, acute decompensated heart failure, and controlled hypotension during surgery. Particularly useful when rapid reduction of blood pressure is required.

Releases nitric oxide, which activates guanylate cyclase in vascular smooth muscle, leading to increased cGMP and smooth muscle relaxation. This causes vasodilation of both arteries and veins, reducing blood pressure and cardiac workload.

Must be administered intravenously with continuous blood pressure monitoring. Can cause cyanide and thiocyanate toxicity with prolonged use. Protect solution from light during administration. Use only in critical care settings with appropriate monitoring equipment. Requires careful titration.

Contraindications

Conditions and patient states where this medication should be avoided or used with caution.

Do not use (1)

ABSOLUTEhypersensitivity

Known allergy to this medication or its components

Use caution (1)

RELATIVEpregnancy

Consult healthcare provider for benefits vs risks assessment

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 24, 2026. · Read our editorial policy